🇺🇸 FDA
Drug

erythromycin lactobionate

Brand: ERYTHROMYCIN

approved

Quick answer

erythromycin lactobionate (ERYTHROMYCIN), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

Key facts

INN
erythromycin lactobionate
Brand
ERYTHROMYCIN
Route
INJECTION
Formulation
INJECTABLE
Originator
TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 8436154

Crystallizing method of erythromycin

Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7129221

6,11-bicyclic erythromycin derivatives

Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is erythromycin lactobionate?

erythromycin lactobionate (ERYTHROMYCIN), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for erythromycin lactobionate?

ERYTHROMYCIN is a marketed brand name for erythromycin lactobionate. Check FDA Drugs@FDA for the current US label holder.